glp 1 $100 a month Customized Compounded GLP-1 Weight Loss Plans Do GLP medications save employers

In February 2026, the FDA publicly announced its intent to take action targeting mass-marketed, non-FDA-approved compounded GLP1 products, emphasizing that promotional claims implying equivalence to FDAapproved drugs can trigger enforcement risk

There can be side effects and risks: GLP-1 drugs affect multiple systems (pancreas, kidney, GI tract) and are not without cost or health implications

But one exploring GLP-1s impacts on consumers and the larger economy would be wise to look beyond healthcare to understand the macro GLP-1 landscape

Our work continues on behalf of TRICARE For Life beneficiaries

Research GLP-1 and incretin peptides semaglutide, tirzepatide, retatrutide and more

Heres how investors can approach this potentially huge opportunity.